Four Doses of Ayahuasca or Esketamine in Major Depressive Disorder: a Double-blind Randomized Trial
Four Doses of Ayahuasca or Esketamine in Major Depressive Disorder: a Double-blind Randomized Trial
Double-blind, randomized trial comparing 4 weekly doses of oral ayahuasca and esketamine in patients with major depression.
Inclusion Criteria:
- Clinical diagnosis of depressive disorder
Exclusion Criteria:
- Presence of psychiatric and other medical comorbidities